Gillian Mearns

Title: Gillian Mearns: Innovator in Therapeutic Bacteriophage Compositions

Introduction

Gillian Mearns is a prominent inventor based in Sydney, Australia. She has made significant contributions to the field of bacteriophage research, holding a total of 5 patents. Her work focuses on developing therapeutic solutions for bacterial infections, showcasing her commitment to advancing medical science.

Latest Patents

Mearns' latest patents include innovative bacteriophage compositions. One of her notable inventions is a composition comprising one or more bacteriophages selected from Sa87, J-Sa36, or Sa83, or their mutants. This invention encompasses the use of these bacteriophage compositions for both medical and non-medical applications, including kits, bandages, and wound dressings. Another significant patent relates to a bacteriophage composition that includes obligately lytic bacteriophages capable of infecting and lysing bacteria, aimed at treating bacterial infections.

Career Highlights

Gillian Mearns is currently associated with Armata Pharmaceuticals, Inc., where she continues to push the boundaries of bacteriophage therapy. Her work is instrumental in developing new treatments that could revolutionize how bacterial infections are managed.

Collaborations

Mearns collaborates with several talented individuals in her field, including Sandra P Morales and Frenk Smrekar. These partnerships enhance her research and contribute to the innovative solutions she develops.

Conclusion

Gillian Mearns is a trailblazer in the field of bacteriophage research, with a focus on therapeutic applications. Her contributions are paving the way for new treatments that could significantly impact public health.